These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15341812)

  • 21. Antimuscarinic drugs.
    McLoughlin C
    Prof Nurse; 2004 Sep; 20(1):50-1. PubMed ID: 15468784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence with antimuscarinic therapy in patients with overactive bladder.
    Haab F; Castro-Diaz D
    Int J Clin Pract; 2005 Aug; 59(8):931-7. PubMed ID: 16033615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of urinary incontinence in older persons.
    Zarowitz BJ; Ouslander JG
    Geriatr Nurs; 2006; 27(5):265-70. PubMed ID: 17045125
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and management of urinary incontinence and functional fecal incontinence (encopresis) in children.
    Nijman RJ
    Gastroenterol Clin North Am; 2008 Sep; 37(3):731-48, x. PubMed ID: 18794006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Chapple C, Khullar V, Gabriel Z, Dooley JA. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 2005;48:5-26.
    Okpara-Kamanu RI
    Eur Urol; 2005 Nov; 48(5):873-4. PubMed ID: 16137823
    [No Abstract]   [Full Text] [Related]  

  • 26. The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms.
    van Leeuwen JH; Castro R; Busse M; Bemelmans BL
    Eur Urol; 2006 Sep; 50(3):440-52; discussion 453. PubMed ID: 16753253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current diagnostics and therapy of the overactive bladder and urge incontinence].
    Badawi JK; Langbein S
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1503-6. PubMed ID: 15942840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overactive bladder: an update.
    Hashim H; Abrams P
    Curr Opin Urol; 2007 Jul; 17(4):231-6. PubMed ID: 17558264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration.
    Wein AJ; Khullar V; Wang JT; Guan Z
    BJU Int; 2007 Feb; 99(2):360-3. PubMed ID: 17155987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlling urinary incontinence.
    Bren L
    FDA Consum; 2005; 39(5):10-5. PubMed ID: 16419286
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
    Kilic N; Balkan E; Akgoz S; Sen N; Dogruyol H
    Int J Urol; 2006 Feb; 13(2):105-8. PubMed ID: 16563131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

  • 33. Overactive bladder: drug therapy versus nerve stimulation.
    Pathak AS; Aboseif SR
    Nat Clin Pract Urol; 2005 Jul; 2(7):310-1. PubMed ID: 16474765
    [No Abstract]   [Full Text] [Related]  

  • 34. "Unblinding" in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident.
    DuBeau CE; Khullar V; Versi E
    Neurourol Urodyn; 2005; 24(1):13-20. PubMed ID: 15570576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality-of-life impact and treatment of urinary incontinence in ethnically diverse older women.
    Huang AJ; Brown JS; Kanaya AM; Creasman JM; Ragins AI; Van Den Eeden SK; Thom DH
    Arch Intern Med; 2006 Oct; 166(18):2000-6. PubMed ID: 17030834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overactive bladder: treatment options in primary care medicine.
    Sussman DO
    J Am Osteopath Assoc; 2007 Sep; 107(9):379-85. PubMed ID: 17908830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolterodine for the treatment of daytime incontinence in children.
    Greenfield SP
    J Urol; 2005 Apr; 173(4):1064. PubMed ID: 15758701
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic management of overactive bladder: practical options for the primary care physician.
    Staskin DR; MacDiarmid SA
    Am J Med; 2006 Mar; 119(3 Suppl 1):24-8. PubMed ID: 16483865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of muscarinic receptor antagonists in urgency and nocturia.
    Michel MC; de la Rosette JJ
    BJU Int; 2005 Sep; 96 Suppl 1():37-42. PubMed ID: 16083453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canadian Urological Association guidelines on urinary incontinence.
    Corcos J; Gajewski J; Heritz D; Patrick A; Reid I; Schick E; Stothers L;
    Can J Urol; 2006 Jun; 13(3):3127-38. PubMed ID: 16813704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.